24 research outputs found
Homologous recombination DNA repair defects in PALB2-associated breast cancers.
Mono-allelic germline pathogenic variants in the Partner And Localizer of BRCA2 (PALB2) gene predispose to a high-risk of breast cancer development, consistent with the role of PALB2 in homologous recombination (HR) DNA repair. Here, we sought to define the repertoire of somatic genetic alterations in PALB2-associated breast cancers (BCs), and whether PALB2-associated BCs display bi-allelic inactivation of PALB2 and/or genomic features of HR-deficiency (HRD). Twenty-four breast cancer patients with pathogenic PALB2 germline mutations were analyzed by whole-exome sequencing (WES, n = 16) or targeted capture massively parallel sequencing (410 cancer genes, n = 8). Somatic genetic alterations, loss of heterozygosity (LOH) of the PALB2 wild-type allele, large-scale state transitions (LSTs) and mutational signatures were defined. PALB2-associated BCs were found to be heterogeneous at the genetic level, with PIK3CA (29%), PALB2 (21%), TP53 (21%), and NOTCH3 (17%) being the genes most frequently affected by somatic mutations. Bi-allelic PALB2 inactivation was found in 16 of the 24 cases (67%), either through LOH (n = 11) or second somatic mutations (n = 5) of the wild-type allele. High LST scores were found in all 12 PALB2-associated BCs with bi-allelic PALB2 inactivation sequenced by WES, of which eight displayed the HRD-related mutational signature 3. In addition, bi-allelic inactivation of PALB2 was significantly associated with high LST scores. Our findings suggest that the identification of bi-allelic PALB2 inactivation in PALB2-associated BCs is required for the personalization of HR-directed therapies, such as platinum salts and/or PARP inhibitors, as the vast majority of PALB2-associated BCs without PALB2 bi-allelic inactivation lack genomic features of HRD.ER
Recommended from our members
Erratum: Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers.
[This corrects the article DOI: 10.1038/s41523-019-0115-9.]
Recommended from our members
Homologous recombination DNA repair defects in PALB2- associated breast cancers
Abstract: Mono-allelic germline pathogenic variants in the Partner And Localizer of BRCA2 (PALB2) gene predispose to a high-risk of breast cancer development, consistent with the role of PALB2 in homologous recombination (HR) DNA repair. Here, we sought to define the repertoire of somatic genetic alterations in PALB2-associated breast cancers (BCs), and whether PALB2-associated BCs display bi-allelic inactivation of PALB2 and/or genomic features of HR-deficiency (HRD). Twenty-four breast cancer patients with pathogenic PALB2 germline mutations were analyzed by whole-exome sequencing (WES, n = 16) or targeted capture massively parallel sequencing (410 cancer genes, n = 8). Somatic genetic alterations, loss of heterozygosity (LOH) of the PALB2 wild-type allele, large-scale state transitions (LSTs) and mutational signatures were defined. PALB2-associated BCs were found to be heterogeneous at the genetic level, with PIK3CA (29%), PALB2 (21%), TP53 (21%), and NOTCH3 (17%) being the genes most frequently affected by somatic mutations. Bi-allelic PALB2 inactivation was found in 16 of the 24 cases (67%), either through LOH (n = 11) or second somatic mutations (n = 5) of the wild-type allele. High LST scores were found in all 12 PALB2-associated BCs with bi-allelic PALB2 inactivation sequenced by WES, of which eight displayed the HRD-related mutational signature 3. In addition, bi-allelic inactivation of PALB2 was significantly associated with high LST scores. Our findings suggest that the identification of bi-allelic PALB2 inactivation in PALB2-associated BCs is required for the personalization of HR-directed therapies, such as platinum salts and/or PARP inhibitors, as the vast majority of PALB2-associated BCs without PALB2 bi-allelic inactivation lack genomic features of HRD
Overlapping mouse subcongenic strains successfully separate two linked body fat QTL on distal MMU 2.
High-resolution mapping of a genetic locus regulating preferential carbohydrate intake, total kilocalories, and food volume on mouse chromosome 17.
Overlapping mouse subcongenic strains successfully separate two linked body fat QTL on distal MMU 2.
BackgroundMouse chromosome 2 is linked to growth and body fat phenotypes in many mouse crosses. With the goal to identify the underlying genes regulating growth and body fat on mouse chromosome 2, we developed five overlapping subcongenic strains that contained CAST/EiJ donor regions in a C57BL/6J (hg/hg) background (hg is a spontaneous deletion of 500 Kb on mouse chromosome 10). To fine map QTL on distal mouse chromosome 2 a total of 1,712 F2 mice from the five subcongenic strains, plus 278 F2 mice from the HG2D founder congenic strain were phenotyped and analyzed. Interval mapping (IM) and composite IM (CIM) were performed on body weight and body fat traits on a combination of SNP and microsatellite markers, which generated a high-density genotyping panel.ResultsPhenotypic analysis and interval mapping of total fat mass identified two QTL on distal mouse chromosome 2. One QTL between 150 and 161 Mb, Fatq2a, and the second between 173.3 and 175.6 Mb, Fatq2b. The two QTL reside in different congenic strains with significant total fat differences between homozygous cast/cast and b6/b6 littermates. Both of these QTL were previously identified only as a single QTL affecting body fat, Fatq2. Furthermore, through a novel approach referred here as replicated CIM, Fatq2b was mapped to the Gnas imprinted locus.ConclusionsThe integration of subcongenic strains, high-density genotyping, and CIM succesfully partitioned two previously linked QTL 20 Mb apart, and the strongest QTL, Fatq2b, was fine mapped to a ~2.3 Mb region interval encompassing the Gnas imprinted locus
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes
Primary pleomorphic adenomas (PAs) and mucoepidermoid carcinomas (MECs) of the breast are vanishingly rare. Here we sought to determine whether breast PAs and MECs would be underpinned by the fusion genes reported to occur in their salivary gland counterparts. Our study included three breast PAs and one breast MEC, which were subjected to RNA sequencing (PAs, n = 2; MEC, n = 1) or to Archer FusionPlex sequencing (PA, n = 1). Our analyses revealed the presence of the HMGA2-WIF1 fusion gene in breast PA3, the CTNNB1-PLAG1 fusion gene in breast PA2, and the CRTC1-MAML2 fusion gene in the breast MEC analyzed (1/1). No oncogenic fusion genes were detected in breast PA1, and no additional oncogenic fusion genes were detected in the cases studied. The presence of the fusion genes identified was validated by fluorescence in situ hybridization (n = 1), reverse transcription-PCR (n = 1), or by both methods (n = 1). Taken together, our findings indicate that PAs and MECs arising in the breast resemble their salivary gland counterparts not only phenotypically but also at the genetic level. Furthermore, our data suggest that the molecular analysis of breast PAs and MECs might constitute a useful tool to aid in their differential diagnosis
High-Resolution Mapping of a Genetic Locus Regulating Preferential Carbohydrate Intake, Total Kilocalories, and Food Volume on Mouse Chromosome 17
<div><p>The specific genes regulating the quantitative variation in macronutrient preference and food intake are virtually unknown. We fine mapped a previously identified mouse chromosome 17 region harboring quantitative trait loci (QTL) with large effects on preferential macronutrient intake-carbohydrate (<i>Mnic1</i>), total kilcalories (<i>Kcal2</i>), and total food volume (<i>Tfv1</i>) using interval-specific strains. These loci were isolated in the [C57BL/6J.CAST/EiJ-17.1<i>-(D17Mit19</i>-<i>D17Mit50)</i>; B6.CAST-17.1] strain, possessing a ∼40.1 Mb region of CAST DNA on the B6 genome. In a macronutrient selection paradigm, the B6.CAST-17.1 subcongenic mice eat 30% more calories from the carbohydrate-rich diet, ∼10% more total calories, and ∼9% more total food volume per body weight. In the current study, a cross between carbohydrate-preferring B6.CAST-17.1 and fat-preferring, inbred B6 mice was used to generate a subcongenic-derived F<sub>2</sub> mapping population; genotypes were determined using a high-density, custom SNP panel. Genetic linkage analysis substantially reduced the 95% confidence interval for <i>Mnic1</i> (encompassing <i>Kcal2</i> and <i>Tfv1</i>) from 40.1 to 29.5 Mb and more precisely established its boundaries. Notably, no genetic linkage for self-selected fat intake was detected, underscoring the carbohydrate-specific effect of this locus. A second key finding was the separation of two energy balance QTLs: <i>Mnic1/Kcal2/Tfv1</i> for food intake and a newly discovered locus regulating short term body weight gain. The <i>Mnic1/Kcal2/Tfv1</i> QTL was further de-limited to 19.0 Mb, based on the absence of nutrient intake phenotypes in subcongenic HQ17IIa mice. Analyses of available sequence data and gene ontologies, along with comprehensive expression profiling in the hypothalamus of non-recombinant, <i>cast/cast</i> and <i>b6/b6</i> F<sub>2</sub> controls, focused our attention on candidates within the QTL interval. <i>Zfp811</i>, <i>Zfp870</i>, and <i>Btnl6</i> showed differential expression and also contain stop codons, but have no known biology related to food intake regulation. The genes <i>Decr2</i>, <i>Ppard</i> and <i>Agapt1</i> are more appealing candidates because of their involvement in lipid metabolism and down-regulation in carbohydrate-preferring animals.</p></div
Differentially expressed genes in the hypothalamus of homozygous <i>cast/cast</i> vs. <i>b6/b6</i> subcongenic-derived F<sub>2</sub> mice, located within the fine mapped QTL interval of 26.08–45.12 Mb.
<p>Positive fold change indicates increased expression, negative value indicates decreased expression in homozygous <i>cast/cast</i> (CC) subcongenic-derived F<sub>2</sub> mice (n = 12) relative to <i>b6/b6</i> (BB) subcongenic-derived F<sub>2</sub> (n = 12). Genes were selected based on a significance value of <i>P</i><0.01 and an expression change of ≥1.5-fold, based on sequence tag counts.</p><p>Differentially expressed genes in the hypothalamus of homozygous <i>cast/cast</i> vs. <i>b6/b6</i> subcongenic-derived F<sub>2</sub> mice, located within the fine mapped QTL interval of 26.08–45.12 Mb.</p
The critical <i>Mnic1/Kcal1</i>/<i>Tfv1</i> QTL region on mouse chromosome 17 was reduced to 19.0 Mb.
<p>Legend: Congenic and subcongenic strains with CAST/EiJ alleles introgressed on the wild type C57BL/6J (B6) or mutant C57BL/6J-<i><sup>hg/hg</sup></i> genome are illustrated. Solid bars indicate CAST donor regions, open bars indicate B6 genotype, and hatched bars designate intervals of undetermined genotype, as defined by SNP or Mit markers (top). The fine-mapped interval encompassing carbohydrate-specific macronutrient intake (<i>Mnic1</i>; peak at 32.49 Mb), total kilocalories (<i>Kcal1</i>; peak at 27.19 Mb) and total food volume (<i>Tfv1</i>; peak at 27.10) is specified by the bar outlined in red.</p